CABA · Cabaletta Bio, Inc. · Congressional Trades
$1.33
-0.12 (-8.28%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— cleared Nov 5, 2026
The latest filing states the doubt was alleviated.
“As disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, we had previously identified conditions that raised substantial doubt about our ability to continue as a going concern. During the quarter ended September 30, 2026, we raised additional funds through the exercise of common stock warrants for proceeds of $115.0 million and sold 1.9 million shares pursuant to the 2025 ATM Program for net proceeds of $6.0 million. As a result of these cash raises, the conditions that previously raised substantial doubt are no longer present.”View the 10-Q filed Nov 5, 2026
Market Cap
$286.91M
Shares
215.72M
Volume · Nov 12
3.73M
Avg daily vol (3M)
5.32M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1759138
CUSIP
12674W109
13F (30d)
80 filings
71 filers
Visit website
Investor relations